伴失神的眼睑肌阵挛患者的电临床特征与长期发作结局
这项多中心回顾性研究纳入172例伴失神的眼睑肌阵挛(EMA)患者,中位起病年龄7岁,中位随访14年,分析预后模式、持续终末缓解(STR)及其预测因素,并通过聚类分析识别出EMA-plus与EMA-only两种内表型,二者在缓解率和认知结局上差异显著。
要点
- 38.4%患者呈非缓解模式,32.6%缓解,29.1%复发;39.5%达到STR,平均潜伏期14.05年。
- 早发起病是最重要的不良治疗反应预测因素;早发、精神共病、热性惊厥(FS)及全面强直-阵挛发作史与较低STR概率相关。
- 聚类分析区分出EMA-plus(早发、智力障碍、EM持续状态、全面阵发性快活动、自我诱发发作、FS、ASM反应差)与EMA-only(缓解率更高、神经精神结局更佳)两簇。
核心结论
- 早发起病是治疗反应不良的最相关预后因素;癫痫起病与ASM反应之间存在长潜伏期,提示年龄相关脑改变可能影响EMA缓解;聚类分析将EMA清晰区分为EMA-plus隐匿亚型与EMA-only良性簇,二者缓解率和认知结局差异显著。
研究设计与样本
- 多中心回顾性研究,纳入随访≥5年的EMA患者172例,中位起病年龄7岁(IQR 5-10岁),中位随访14年(IQR 8.25-23.75年);采用多项式 logistic 回归、Cox 比例风险模型及两步聚类分析。
主要发现
- 66例(38.4%)为非缓解模式,56例(32.6%)为缓解模式,50例(29.1%)为复发模式。
- 68例(39.5%)达到STR,平均潜伏期14.05年(SD ±12.47年)。
- 172例中62例尝试停用ASM,其中74.2%发作复发。
- 聚类分析得到两个簇各86例:簇2(EMA-plus)以更早起病年龄、更高智力障碍率、EM持续状态、全面阵发性快活动、自我诱发发作、FS及ASM反应差为特征;簇1(EMA-only)以更高发作缓解率和更佳神经精神结局为特征。
关键数值与推荐
- 多项式 logistic 回归显示早发起病、热性惊厥(FS)史及EM持续状态显著预测非缓解模式。
- Cox 比例风险模型显示早发起病、精神共病、FS史及全面强直-阵挛发作史与较低STR概率相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Eyelid myoclonia (EM) with absences (EMA) is a generalized epilepsy syndrome with a prognosis and clinical characteristics that are still partially undefined. We investigated electroclinical endophenotypes and long-term seizure outcome in a large cohort of patients with EMA. METHODS: In this multicenter retrospective study, patients with EMA with ≥5 years of follow-up were included. We investigated prognostic patterns and sustained terminal remission (STR), along with their prognostic factors. Moreover, a 2-step cluster analysis was used to investigate the presence of distinct EMA endophenotypes. RESULTS: We included 172 patients with a median age at onset of 7 years (interquartile range [IQR] 5-10 years) and a median follow-up duration of 14 years (IQR 8.25-23.75 years). Sixty-six patients (38.4%) displayed a nonremission pattern, whereas remission and relapse patterns were encountered in 56 (32.6%) and 50 (29.1%) participants. Early epilepsy onset, history of febrile seizures (FS), and EM status epilepticus significantly predicted a nonremission pattern according to multinomial logistic regression analysis. STR was achieved by 68 (39.5%) patients with a mean latency of 14.05 years (SD ±12.47 years). Early epilepsy onset, psychiatric comorbid conditions, and a history of FS and generalized tonic-clonic seizures were associated with a lower probability of achieving STR according to a Cox regression proportional hazards model. Antiseizure medication (ASM) withdrawal was attempted in 62 of 172 patients, and seizures recurred in 74.2%. Cluster analysis revealed 2 distinct clusters with 86 patients each. Cluster 2, which we defined as EMA-plus, was characterized by an earlier age at epilepsy onset, higher rate of intellectual disability, EM status epilepticus, generalized paroxysmal fast activity, self-induced seizures, FS, and poor ASM response, whereas cluster 1, the EMA-only cluster, was characterized by a higher rate of seizure remission and more favorable neuropsychiatric outcome. DISCUSSION: Early epilepsy onset was the most relevant prognostic factor for poor treatment response. A long latency between epilepsy onset and ASM response was observed, suggesting the effect of age-related brain changes in EMA remission. Last, our cluster analysis showed a clear-cut distinction of patients with EMA into an EMA-plus insidious subphenotype and an EMA-only benign cluster that strongly differed in terms of remission rates and cognitive outcomes.
引用
- Cerulli Irelli E, Cocchi E, Ramantani G, et al. Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences. Neurology. 2022. PMID: 35292555. doi:10.1212/WNL.0000000000200165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。